Flu Vaccine And Omicron Uncertainty Weighs On Moderna Stock. Time To Buy?

Moderna stock has seen a fair bit of volatility, declining by over 20% since early December. The sell-off comes amid the spread of the highly infectious omicron variant of the coronavirus. While Moderna hasn't yet provided information on how effective its vaccine is against omicron, the company's...